Safety factors and establishment of acceptable daily intakes

10.3109/00498258409151404

10.1016/0273-2300(83)90025-9

10.1016/0273-2300(83)90026-0

10.1016/0006-2952(89)90385-7

Doull J., 1980, The Basic Science of Poisons, 2

10.1007/BF00311057

10.3109/10408448509041323

10.1002/jps.2600721003

Gilman A. G., 1985, Goodman and Gilman's The Pharmacological Basis of Therapeutics, 7

Hayes A. W., 1989, Principles and Methods of Toxicology, 2

10.3109/00498258609043509

10.3109/00498258609043527

10.1016/0273-2300(88)90006-2

10.1002/jps.2600741017

Nelson E., 1966, Journal of Pharmacology and Experimental Therapeutics, 153, 159

10.3109/00498258109045276

10.1016/0278-6915(85)90136-X

Renwick A. G., 1989, Principles and Methods of Toxicology, 835

Renwick A. G., 1989, Sulphur‐containing Drugs and Related Organic Compounds, 3, 165

Renwick A. G., 1972, Biochemical Journal, 129, 869, 10.1042/bj1290869

Renwick A. G., 1988, British Journal of Clinical Pharmacology, 25, 701, 10.1111/j.1365-2125.1988.tb05256.x

10.3109/00498258609050255

10.1016/0041-008X(89)90228-7

10.3109/00498258709043936

10.3109/00498258809167522

10.3109/00498258609043538

Strong H. A., 1984, Journal of Pharmacology and Experimental Therapeutics, 230, 726

10.1016/0041-008X(80)90215-X

10.3109/00498258109045864

10.3109/00498258809055133

Vainio, H., Hietanen, E. and Belvedere, G. 1984.Pharmacokinetics and metabolism of styrene, Progress in Drug Metabolism, Vol. 8, 203–239. London: Taylor and Francis.

10.3109/03602537808993770

10.3109/03602538208991375